No association of genetic variants of liver X receptor-beta with Alzheimer's disease risk

Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):650-3. doi: 10.1002/ajmg.b.30652.

Abstract

Apolipoprotein E (APOE) epsilon4 allele is the strongest hitherto known risk factor for sporadic Alzheimer's disease (AD). Liver X receptor-beta (LXRbeta) is a transcription factor that controls expression of genes involved in brain cholesterol metabolism, and one of the main LXRbeta targets is APOE. To evaluate the relationship between LXRbeta genetic variants and AD, independently or in concert with the APOE epsilon4 allele, we examined three LXRbeta polymorphisms located in introns 2 (rs 2695121), 5 (rs 1052533), and 7 (rs 1405655), in 414 Spanish AD patients and 447 controls. The current study does not demonstrate an association between LXRbeta genotypes or haplotypes and AD, neither in the total sample nor when the populations were stratified for the presence or absence of the APOE epsilon4 allele.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics
  • Apolipoprotein E4 / metabolism
  • Case-Control Studies
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / physiology
  • Female
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Genotype
  • Haplotypes
  • Humans
  • Liver X Receptors
  • Male
  • Middle Aged
  • Orphan Nuclear Receptors
  • Receptors, Cytoplasmic and Nuclear / genetics*
  • Receptors, Cytoplasmic and Nuclear / physiology
  • Risk Factors
  • Spain / epidemiology

Substances

  • Apolipoprotein E4
  • DNA-Binding Proteins
  • Liver X Receptors
  • Orphan Nuclear Receptors
  • Receptors, Cytoplasmic and Nuclear